跳至主要内容
临床试验/CTRI/2013/10/004115
CTRI/2013/10/004115已完成不适用

Laparoscopic Ileal Interposition with Sleeve Gastrectomy for control of Type-2 Diabetes

Kirloskar Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2008年2月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
Reduction or Stoppage of anti-diabetic medication

研究概览

简要总结

This study is a single arm trial to evaluate efficacy of ileal interposition with sleeve gastrectomy surgery on control of type 2 diabetes mellitus. The study will be conducted at Kirloskar Hospital, Hyderabad in 30 patients. Primary outcome will be to assess reduction/stoppage of anti-diabetic medication in 3 months - 12 months. Secondary outcome will measure glycosylated hemoglobin A1C levels at 6 months & 12 months after surgery

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Diagnosed Type 2 Diabetes for 2-30 years
  • C-Peptide levels of more than 1ng/ml
  • Patients with any BMI
  • Age between 20 and 70 (both men & women included)
  • Able to provide Informed Consent.
  • Able to comply with follow-up tests and check-up.

排除标准

  • 1.Pregnancy
  • Patients who have an incurable malignant or debilitating disease.
  • Serious uncorrectable impairment of coagulation (INR>1.4, PTT > + 3 secs), lungs, kidney or heart
  • Diagnosed severe eating disorder
  • Untreated endocrine disorder
  • Active peptic ulcer
  • Untreated H.
  • Cognitive Impairment.

结局指标

主要结局

Reduction or Stoppage of anti-diabetic medication

时间窗: 3, 6, 9 and 12 months

次要结局

  • Glycemic Control with HbA1C 6.5(6 and 12 months)

研究者

申办方类型
Private hospital/clinic

研究点 (1)

Loading locations...

相似试验

Laparoscopic Ileal Interposition with Sleeve... | 临床试验